Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection
Ulrich Julius Lipidology and Center for Extracorporeal Therapy, Department for Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany Abstract: This review reports the current situation with respect to therapeutic options (lifest...
Main Author: | Julius U |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-10-01
|
Series: | Medical Devices : Evidence and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/lipoprotein-apheresis-in-the-management-of-severe-hypercholesterolemia-peer-reviewed-article-MDER |
Similar Items
-
LIPOPROTEIN APHERESIS: YESTERDAY, TODAY, TOMORROW. REVIEW
by: U. Julius, et al.
Published: (2018-09-01) -
Why Some Patients Undergoing Lipoprotein Apheresis Therapy Develop New Cardiovascular Events?
by: Ulrich Julius, et al.
Published: (2020-07-01) -
Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)
by: Tina Z. Khan, et al.
Published: (2021-01-01) -
Current Role of Lipoprotein Apheresis in the Treatment of High-Risk Patients
by: Ulrich Julius
Published: (2018-05-01) -
Just not cosmesis! Role of low-density lipoprotein apheresis in familial hypercholesterolemia: Experience at a newly developed tertiary care institution in Northern India
by: Daljit Kaur, et al.
Published: (2021-01-01)